Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch
Authors:
- Kristjan H. GretarssonKGKristjan H. Gretarsson
- Susan L. GloorSGSusan L. Gloor
- Daniel N. WeinbergDWDaniel N. Weinberg
- Jamie L. McCuistonJMJamie L. McCuiston
- Vishnu Udayakumar Sunitha KumaryVKVishnu Udayakumar Sunitha Kumary
- Allison R. HickmanAHAllison R. Hickman
- Rachel LeeRLRachel Lee
- Natalie LytellNLNatalie Lytell
- Samuel FlashnerSFSamuel Flashner
Open Access
- 30 August 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (35) , eadp0975
Abstract
During tumor development, promoter CpG islands that are normally silenced by Polycomb repressive complexes (PRCs) become DNA-hypermethylated. The molecular mechanism by which de novo DNA methyltransferase(s) [DNMT(s)] catalyze CpG methylation at PRC-regulated regions remains unclear. Here, we report a cryo–electron microscopy structure of the DNMT3A long isoform (DNMT3A1) amino-terminal region in complex with a nucleosome carrying PRC1-mediated histone H2A lysine-119 monoubiquitination (H2AK119Ub). We identify regions within the DNMT3A1 amino terminus that bind H2AK119Ub and the nucleosome acidic patch. This bidentate interaction is required for effective DNMT3A1 engagement with H2AK119Ub-modified chromatin in cells. Further, aberrant redistribution of DNMT3A1 to Polycomb target genes recapitulates the cancer-associated DNA hypermethylation signature and inhibits their transcriptional activation during cell differentiation. This effect is rescued by disruption of the DNMT3A1–acidic patch interaction. Together, our analyses reveal a binding interface critical for mediating promoter CpG island DNA hypermethylation, a major molecular hallmark of cancer.Keywords
All Related Versions
This publication has 101 references indexed in Scilit:
- DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanismsSeminars in Cancer Biology, 2002
- A Novel Dnmt3a Isoform Produced from an Alternative Promoter Localizes to Euchromatin and Its Expression Correlates with Activede Novo MethylationJournal of Biological Chemistry, 2002
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in miceDevelopment, 2002
- Dnmt3L and the Establishment of Maternal Genomic ImprintsScience, 2001
- DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian DevelopmentCell, 1999
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999
- New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioningJournal of Molecular Biology, 1998
- Methylation of the BRCA1 gene in sporadic breast cancer.1997
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995